Examkin

All practice questions

4736 questions

All types4,736Multiple choice2,413Multiple select567Numeric127Matching858Ordering771
Question 2881Question →

An ambulatory appointment is scheduled for a 41-year-old male delivery driver to evaluate his blood pressure management. He was diagnosed with primary hypertension six months ago and was prescribed daily amlodipine. He also has a history of moderate persistent asthma, which is well controlled on a daily inhaled corticosteroid-formoterol inhaler.

During today's visit, his blood pressure is 158/98 mmHg and his heart rate is 76/min. When asked about his medication usage, the patient states, "I only take the blood pressure pill when my neck gets stiff or I feel a headache coming on. Otherwise, I feel completely normal, so I try to avoid putting unnecessary chemicals into my body."

Which of the following is the most appropriate initial response by the physician?

Show answer & explanation

Answer: Can you explain to me your understanding of what high blood pressure does to your body when you do not have symptoms?

Answer

The most appropriate initial response is to ask the patient to explain their understanding of how high blood pressure affects the body in the absence of symptoms.
The correct response utilizes an open-ended question to explore the patient's underlying health beliefs. This patient exhibits a common misconception that hypertension is a symptomatic disease requiring treatment only during 'flare-ups' (e.g., headaches). Assessing the patient's illness perception is the fundamental first step in patient counseling. It allows the physician to understand the root cause of the non-adherence and creates a non-judgmental opening to provide targeted health education—specifically, explaining that hypertension often causes silent, progressive end-organ damage even when a person feels completely normal.

Step-by-Step Solution

1
Identify the primary barrier to medication adherence presented in the vignette.
The patient believes that hypertension medications are only necessary when acute symptoms (like neck stiffness or headaches) are present.
Recognizing the specific health misconception is required before formulating an educational or counseling intervention.
2
Select the communication strategy that best addresses the identified barrier.
Use an open-ended question to explore the patient's illness representation and health literacy.
Directly challenging the patient, using fear tactics, or assuming alternative causes (like side effects) can damage the therapeutic alliance. Exploring their understanding allows the physician to gently introduce corrective health education about hypertension being a 'silent' disease.
3
Evaluate the remaining options for clinical and ethical appropriateness.
Eliminate options that prescribe contraindicated medications (nonselective beta-blockers in asthma), misapply screening guidelines (colonoscopy at age 41), or defensively terminate counseling.
Physician counseling must maintain clinical safety and adhere to evidence-based guidelines while fostering patient autonomy.

Key Concept

When patients exhibit non-adherence due to a misunderstanding of their disease process (e.g., treating asymptomatic hypertension as a symptom-driven illness), the physician should first use open-ended inquiry to explore the patient's health beliefs before providing corrective education.
Question 2882Question →

A randomized, double-blind, placebo-controlled trial is conducted to evaluate the efficacy of a novel glucagon-like peptide-1 (GLP-1) receptor agonist for the secondary prevention of major adverse cardiovascular events (MACE). The study enrolls patients with type 2 diabetes mellitus and established cardiovascular disease. Participants are randomized in a 1:1 ratio to receive either the GLP-1 receptor agonist or a placebo, in addition to standard of care.

Over a 3-year follow-up period, the investigators report the following outcomes:

GroupTotal Patients (nn)MACE Occurred
Placebo20002000260260
GLP-1 Receptor Agonist20002000160160

Based on the study results, what is the number needed to treat (NNT) with the novel GLP-1 receptor agonist to prevent one major adverse cardiovascular event over the 3-year follow-up period?

Show answer & explanation

Answer: 20

Answer

20
The number needed to treat (NNT) is an epidemiological measure used to evaluate the clinical impact of an intervention. It is calculated as the inverse of the Absolute Risk Reduction (ARR), using the formula NNT=1ARRNNT = \frac{1}{ARR}. First, determine the event rates for both groups. The Control Event Rate (CER) is 2602000=0.13\frac{260}{2000} = 0.13 (13%13\%), and the Experimental Event Rate (EER) is 1602000=0.08\frac{160}{2000} = 0.08 (8%8\%). The ARR is the absolute difference between these two rates: 0.13−0.08=0.050.13 - 0.08 = 0.05 (5%5\%). The NNT is therefore 10.05=20\frac{1}{0.05} = 20. This indicates that 2020 patients must be treated with the novel GLP-1 receptor agonist over a 3-year period to prevent one major adverse cardiovascular event.

Step-by-Step Solution

1
Calculate the Control Event Rate (CER).
CER=2602000=0.13CER = \frac{260}{2000} = 0.13 (13%13\%)
To determine the baseline risk of the adverse event in the untreated (placebo) population.
2
Calculate the Experimental Event Rate (EER).
EER=1602000=0.08EER = \frac{160}{2000} = 0.08 (8%8\%)
To determine the risk of the adverse event in the population receiving the intervention.
3
Calculate the Absolute Risk Reduction (ARR).
ARR=CER−EER=0.13−0.08=0.05ARR = CER - EER = 0.13 - 0.08 = 0.05 (5%5\%)
To find the absolute difference in event risk between the control and intervention groups.
4
Calculate the Number Needed to Treat (NNT).
NNT=1ARR=10.05=20NNT = \frac{1}{ARR} = \frac{1}{0.05} = 20
To determine how many patients need to receive the intervention to prevent one additional adverse event.

Key Concept

The Number Needed to Treat (NNT) is the inverse of the Absolute Risk Reduction (ARR) and represents the number of patients who must receive a specific intervention over a defined time period to prevent one additional adverse outcome.
Question 2883Question →

A 75-year-old woman is evaluated in the emergency department for sudden-onset right-sided pleuritic chest pain and mild shortness of breath that began 6 hours ago. She has a history of essential hypertension and osteoarthritis. Current medications include lisinopril and acetaminophen. Vital signs are temperature 37.1°C (98.8°F), blood pressure 138/86 mm Hg, pulse 104/min, and respirations 18/min. Oxygen saturation is 96% on room air. Physical examination is unremarkable except for mild, chronic right lower extremity edema. The patient is alert, comfortable, and conversing in full sentences. Laboratory evaluation shows a serum creatinine of 1.0 mg/dL. High-sensitivity troponin I is undetectable, and N-terminal pro-B-type natriuretic peptide (NT-proBNP) is 85 pg/mL (normal: <125 pg/mL). CT pulmonary angiography reveals a segmental pulmonary embolism in the right lower lobe. Transthoracic echocardiography demonstrates normal right ventricular size and systolic function without evidence of right heart strain. The patient is administered a dose of oral apixaban. Her pain is completely relieved with oral analgesics. She lives with her healthy, supportive daughter 15 minutes away from the hospital and is ambulatory at baseline. Which of the following is the most appropriate disposition for this patient?

Show answer & explanation

Answer: Discharge home with oral anticoagulation and prompt outpatient follow-up

Answer

The most appropriate disposition is to discharge the patient home with oral anticoagulation and prompt outpatient follow-up.
The correct disposition is discharging the patient home with oral anticoagulation and prompt outpatient follow-up. The standard of care for acute pulmonary embolism has evolved significantly to favor outpatient management for carefully selected individuals. Patients who are hemodynamically stable, have a low-risk clinical score (such as a simplified Pulmonary Embolism Severity Index [sPESI] of 0), possess normal right ventricular function on imaging, and exhibit negative cardiac biomarkers are definitively classified as low risk. When these objective medical criteria are met alongside adequate social support, well-controlled pain, and no contraindications to direct oral anticoagulants, the patient should be discharged directly from the emergency department.

Step-by-Step Solution

1
Evaluate the patient's hemodynamic status.
The patient is hemodynamically stable with a blood pressure of 138/86 mm Hg.
Hemodynamic instability would classify the event as a massive (high-risk) pulmonary embolism, necessitating intensive care and reperfusion therapy.
2
Assess clinical risk using a validated stratification tool such as the simplified Pulmonary Embolism Severity Index (sPESI).
The patient has an sPESI score of 0 (age < 80, no cancer, no chronic cardiopulmonary disease, heart rate < 110/min, systolic BP >= 100 mm Hg, O2 sat >= 90%).
An sPESI score of 0 identifies the patient as being at very low clinical risk for short-term mortality.
3
Review cardiac biomarkers and right ventricular imaging.
Troponin and NT-proBNP are normal, and there is no evidence of right ventricular strain on echocardiography.
The absence of right ventricular dysfunction and myocardial necrosis rules out an intermediate-risk (submassive) pulmonary embolism, confirming the patient remains in the low-risk category.
4
Assess social and functional factors to determine the final care setting.
The patient is ambulatory, her pain is well-controlled with oral analgesics, and she has strong home support from her daughter.
Low-risk patients with adequate social support and no bleeding contraindications should be discharged home to avoid the unnecessary risks and costs associated with hospitalization.

Key Concept

Risk stratification of acute pulmonary embolism using clinical scores, biomarkers, and echocardiography to identify low-risk patients eligible for safe outpatient management.
Question 2884Question →

A pulmonology research consortium is planning a clinical trial to evaluate a novel inhaled bronchodilator for the symptomatic management of moderate, stable chronic obstructive pulmonary disease (COPD). To maximize statistical efficiency due to funding constraints and a limited patient pool, the investigators choose a design where each enrolled participant is randomized to receive either the novel bronchodilator or a matching placebo for four weeks. Subsequently, following a two-week intervention-free interval, participants who initially received the active drug will receive the placebo, and those who received the placebo will receive the active drug for another four weeks. The primary outcome is the mean change in daily breathlessness scores.

Which of the following conditions is an essential requirement for this specific study design to yield valid results?

Show answer & explanation

Answer: The physiological effects of the initial therapeutic assignment must be completely resolved before the second evaluation period begins.

Answer

The physiological effects of the initial therapeutic assignment must be completely resolved before the second evaluation period begins.
The clinical vignette describes a crossover randomized controlled trial. In this study design, each participant receives a sequence of different treatments, effectively serving as their own control. A unique and critical vulnerability of this design is the 'carryover effect,' which occurs when the physiological, pharmacological, or psychological effects of the first treatment persist into the second treatment phase, thereby confounding the results. To mitigate this threat and ensure internal validity, an adequate 'washout period' (the intervention-free interval described in the stem) must be implemented. This period must be sufficiently long to ensure that the physiological effects of the initial therapeutic assignment have completely resolved and the patient has returned to their baseline state before the second evaluation period begins.

Step-by-Step Solution

1
Identify the specific study design described in the clinical vignette.
The scenario describes a crossover randomized controlled trial, as each patient receives both the active drug and the placebo sequentially, separated by an intervention-free interval.
Recognizing the study design is the necessary first step to understanding its inherent methodological strengths and weaknesses.
2
Determine the unique threats to internal validity associated with this study design.
The primary threat is the 'carryover effect,' where the physiological or psychological impacts of the first treatment persist into the second treatment period.
Understanding what can compromise the data allows investigators to implement specific design requirements to protect validity.
3
Evaluate the options to identify the requirement that directly mitigates this specific threat.
The requirement that all effects of the initial therapy must be completely resolved describes the purpose of the 'washout period' (the intervention-free interval).
If the effects are not completely resolved, the patient's baseline for the second phase is altered, severely biasing the final within-subject comparison.

Key Concept

Crossover Study Design Requirements and Limitations
Estimated Time:1m 30s
Question 2885Question →

During a routine outpatient visit, a physician sees a 62-year-old female with a known history of severe chronic obstructive pulmonary disease (COPD) and a 40-pack-year smoking history. Upon entering the examination room, the physician notes a strong odor of tobacco smoke on the patient's clothing. When the physician gently asks about her current tobacco use, the patient crosses her arms, raises her voice, and states, "My grandfather smoked a pack a day until he died peacefully at 90! Besides, you already told me my lungs are permanently damaged, so putting myself through the misery of quitting now won't fix anything." Which of the following is the most appropriate initial response by the physician?

Show answer & explanation

Answer: It sounds like you believe that going through the difficult process of quitting would not offer you any meaningful health benefits at this point.

Answer

The statement reflecting the patient's belief that quitting would not offer meaningful health benefits.
The patient is in the precontemplation stage of change, characterized by resistance and a lack of intent to modify her behavior. According to the principles of motivational interviewing, the most effective initial step when encountering resistance is to utilize reflective listening. By stating, 'It sounds like you believe...', the physician acknowledges and validates the patient's perspective without agreeing or judging. This approach de-escalates defensiveness, builds therapeutic rapport, and allows the physician to eventually ask permission to provide education (the 'Ask-Tell-Ask' framework). Confrontational tactics, ultimatums, or unsolicited medical facts are counterproductive at this stage.

Step-by-Step Solution

1
Assess the patient's readiness to change.
The patient is defensive, minimizes the risks (citing her grandfather), and denies the benefits of quitting, indicating she is in the precontemplation stage.
Identifying the stage of change dictates the appropriate counseling framework.
2
Select the appropriate communication strategy for the precontemplation stage.
Avoid argumentation, scare tactics, or immediate advice-giving. Instead, use motivational interviewing techniques such as reflective listening.
Confronting a defensive patient directly increases resistance, whereas validating their current emotional state builds rapport and opens the door for future interventions.
3
Evaluate the distractors for factual and ethical accuracy.
The other options contain medical, ethical, or pharmacokinetic inaccuracies and utilize coercive or confrontational language.
In standardized assessments, distractors in communication questions often combine poor interpersonal tone with specific clinical misconceptions.

Key Concept

Motivational interviewing techniques (reflective listening) for patients in the precontemplation stage of behavioral change.
Question 2886Question →

A 64-year-old man with end-stage liver disease due to alcohol use disorder is brought to the emergency department by his daughter after vomiting large amounts of blood at home. On presentation, his blood pressure is 80/50 mm Hg, and his heart rate is 125/min. Physical examination reveals jaundice, marked ascites, and asterixis. He is lethargic and oriented only to his name. An advance directive in his electronic medical record explicitly names his daughter as his healthcare surrogate and states he does not want mechanical ventilation under any circumstances. The medical team determines he requires immediate endotracheal intubation for airway protection prior to urgent upper endoscopy. The physician explains the situation to the daughter, who refuses consent for intubation, stating, "He made it very clear he never wanted to be on a breathing machine, even if it meant he would die." When the physician briefly rouses the patient and asks what he wants, he mumbles, "Help me, don't let me die," before falling back asleep. Which of the following is the most appropriate next step in the management of this patient?

Show answer & explanation

Answer: Honor the daughter's refusal and provide non-invasive medical management

Answer

Honor the daughter's refusal and provide non-invasive medical management
The correct course of action is to honor the daughter's refusal and provide non-invasive medical management. This patient currently lacks clinical decision-making capacity due to hepatic encephalopathy, as demonstrated by his disorientation, lethargy, and asterixis. When a patient lacks capacity, medical decisions fall to their legally appointed healthcare surrogate. The surrogate is expected to exercise substituted judgment—making the decision the patient would have made if they possessed capacity. Because the advance directive explicitly names the daughter and outlines a refusal of mechanical ventilation, her decision must be respected. The patient's momentary plea does not override the directive because he lacks the capacity to fully comprehend his medical situation and change his goals of care.

Step-by-Step Solution

1
Assess the patient's clinical decision-making capacity.
The patient has asterixis, lethargy, and disorientation, indicating hepatic encephalopathy. He lacks clinical capacity.
Capacity is required for a patient to make or change medical decisions. Without it, a surrogate must step in.
2
Identify the appropriate decision-maker.
The advance directive explicitly names the daughter as the healthcare surrogate.
Legally designated surrogates in an advance directive take precedence over default next-of-kin hierarchies.
3
Determine the surrogate's decision and its ethical basis.
The daughter refuses intubation based on the patient's previously stated wishes.
Surrogates must use substituted judgment, making the decision the patient would have made if they had capacity.
4
Implement the management plan.
Respect the surrogate's decision to refuse intubation and proceed with non-invasive care.
Honoring patient autonomy through their chosen surrogate is the ethical and legal standard.

Key Concept

In patients lacking clinical capacity, medical decisions must be guided by their designated healthcare surrogate using substituted judgment based on the patient's advance directives, even if the incapacitated patient expresses momentary conflicting desires.
Question 2887Question →

A 54-year-old man presents to the clinic for a follow-up evaluation. One month ago, his blood pressure was 152/96 mm Hg, and today it is 154/98 mm Hg. His medical history is significant for osteoarthritis and a recently diagnosed active gastric ulcer. At the previous visit, the physician recommended initiating amlodipine. Today, the patient admits he never filled the prescription. He states, "I read on an internet forum that blood pressure pills destroy your kidneys. I refuse to take them. Instead, I am going to strictly limit my salt intake and start taking high-dose ibuprofen every day for my joint pain so I can start jogging." He insists on proceeding with this alternative plan.

Which of the following statements by the physician represents the most appropriate initial counseling approach?

Show answer & explanation

Answer: Limiting your salt intake and preparing to exercise are excellent goals. Can you tell me more about what you read regarding blood pressure medications and kidney damage?

Answer

The most appropriate response is to validate the patient's positive lifestyle intentions while using an open-ended question to explore his specific fears about kidney damage.
The correct response utilizes core principles of motivational interviewing and patient-centered communication. When a patient presents with medical misinformation and resistance to therapy, directly confronting them or lecturing them often entrenches their resistance. The most effective initial step is to validate the positive aspects of their plan (e.g., limiting salt intake and preparing to exercise) to build a therapeutic alliance. Following this, the physician should use an open-ended question to explore the patient's specific health beliefs and fears. Understanding exactly what the patient read about kidney damage provides the physician with the context needed to gently and effectively correct the misconception in subsequent dialogue.

Step-by-Step Solution

1
Identify the primary barrier to medication adherence.
The patient is refusing amlodipine due to a specific misconception (fear of kidney destruction) derived from an internet forum.
Understanding the root cause of non-adherence dictates the counseling strategy.
2
Evaluate the patient's proposed alternative plan for clinical safety.
The patient plans to start a low-salt diet, exercise, and take high-dose ibuprofen. While diet and exercise are positive, high-dose NSAIDs are absolutely contraindicated given his active gastric ulcer and uncontrolled hypertension.
The physician must address both the non-adherence and the dangerous self-medication plan.
3
Select the optimal initial communication strategy.
The physician should first validate the patient's positive efforts (salt restriction, desire to exercise) to build a therapeutic alliance, and then use an open-ended question to explore the misinformation regarding kidney damage.
Directly arguing with the patient or lecturing them often increases resistance. Exploring their beliefs first allows the physician to provide targeted, respectful education subsequently.

Key Concept

Patient-Centered Communication and Motivational Interviewing
Question 2888Question →

A cohort study is conducted to evaluate the risk of hepatotoxicity associated with a novel antifungal agent, MycoStop, compared to standard fluconazole therapy in adult patients. The study follows 5,0005,000 patients prescribed MycoStop and 5,0005,000 patients prescribed fluconazole over a 12-month period. At the end of the follow-up, 250250 patients in the MycoStop group and 5050 patients in the fluconazole group developed signs of hepatotoxicity.

During the data analysis, researchers perform a stratified analysis to account for concurrent daily use of acetaminophen. The relative risk (RR) of hepatotoxicity with MycoStop compared to fluconazole is found to be 6.26.2 in patients taking acetaminophen daily, and 1.51.5 in patients who do not take acetaminophen. The crude relative risk for the entire cohort is 5.05.0.

Based on these results, what is the Number Needed to Harm (NNH) for MycoStop compared to fluconazole, and how should concurrent acetaminophen use be classified?

Show answer & explanation

Answer: NNH = 2525; concurrent acetaminophen use is an effect modifier

Answer

NNH = 2525; concurrent acetaminophen use is an effect modifier
The correct answer accurately calculates the Absolute Risk Increase as 0.040.04 (0.05−0.010.05 - 0.01), which results in a Number Needed to Harm (NNH) of 2525 (1/0.041/0.04). Furthermore, because the stratum-specific relative risks (6.26.2 and 1.51.5) are substantially different from each other, concurrent acetaminophen use modifies the effect of MycoStop on hepatotoxicity, making it an effect modifier.

Step-by-Step Solution

1
Calculate the incidence of hepatotoxicity in both the exposed and unexposed groups.
MycoStop incidence = 250/5,000=0.05250 / 5,000 = 0.05 (5%5\%). Fluconazole incidence = 50/5,000=0.0150 / 5,000 = 0.01 (1%1\%).
Baseline and exposed risk rates are required to determine the absolute impact of the new medication.
2
Calculate the Absolute Risk Increase (ARI) and Number Needed to Harm (NNH).
ARI = 0.05−0.01=0.040.05 - 0.01 = 0.04. NNH = 1/0.04=251 / 0.04 = 25.
NNH is defined as the inverse of the ARI, representing the number of patients treated to cause one additional adverse event.
3
Compare the crude relative risk (RR) with the stratum-specific RRs to determine the role of acetaminophen use.
The stratum-specific RRs (6.26.2 and 1.51.5) are significantly different from each other.
When stratum-specific measures of association differ substantially from one another, it indicates effect modification, meaning the third variable biologically modifies the exposure-outcome relationship.

Key Concept

The Number Needed to Harm (NNH) is calculated as 1/Absolute Risk Increase (ARI)1 / \text{Absolute Risk Increase (ARI)}. Effect modification is present when the measure of association differs significantly across strata of a third variable.
Question 2889Question →

A physician is evaluating four different patients in an outpatient clinic. Each patient expresses a specific barrier to adhering to their recommended medical management. Match each patient statement to the most appropriate initial physician counseling strategy.

Click a left item, then click its matching right item

Items

Patient with asthma: 'I only use my daily steroid inhaler when my chest feels tight, which is usually right before I go for a run.'
Patient with diabetes: 'My mother went blind from diabetes, so I know it is just a matter of time before I lose my vision too, regardless of my diet.'
Patient with hypertension: 'I stopped taking my hydrochlorothiazide because it makes me have to use the restroom repeatedly during my long commute to work.'
Patient who smokes: 'I understand smoking is bad for my heart, but it is the only way I can calm down after dealing with difficult customers all day.'

Matches

Show answer & explanation

Answer

The asthma patient requires clarification on controller versus rescue therapies; the diabetic patient requires addressing fatalistic beliefs; the hypertensive patient requires medication timing adjustment; and the smoking patient requires exploring alternative stress reduction techniques.
Effective patient counseling requires matching the physician's intervention to the specific barrier identified. A knowledge deficit (asthma) requires targeted education; fatalism (diabetes) requires cognitive reframing and emphasizing agency; an unacceptable side effect (hypertension) requires practical medical adjustment; and emotional reliance (smoking) requires validating the emotion while collaborating on substituting the behavior.

Step-by-Step Solution

1
Analyze the asthma patient's statement.
Identified a knowledge gap regarding medication purpose.
Using a daily steroid only for acute symptoms indicates a misunderstanding of maintenance versus rescue therapy.
2
Analyze the diabetic patient's statement.
Identified fatalism and lack of perceived control.
The belief that complications are inevitable regardless of behavior requires cognitive reframing to improve self-efficacy.
3
Analyze the hypertensive patient's statement.
Identified a lifestyle-limiting medication side effect.
Diuretic-induced polyuria during a commute is a practical barrier that can often be resolved by altering the dosing schedule.
4
Analyze the smoking patient's statement.
Identified smoking as a primary coping mechanism for stress.
Before behavior change can occur, the physician must validate the psychological function of the habit and help substitute it.

Key Concept

Identifying and targeting the specific patient barrier (knowledge deficit, psychological reliance, or practical obstacle) is essential for effective health education and improving adherence.
Estimated Time:1m 30s
Question 2890Question →

A clinical research committee is evaluating several proposed study protocols. Match each epidemiological research scenario with the most appropriate study design.

Click a left item, then click its matching right item

Items

An investigator aims to determine if episodes of acute anger serve as a trigger for sudden cardiac death. To minimize between-patient confounding, the exposure during the hour immediately preceding the event is compared to the exposure during a control period in the same individual.
A public health physician analyzes aggregated national data from 25 countries to evaluate the correlation between per capita alcohol consumption and the incidence of esophageal cancer in those populations.
A health system evaluates a newly approved oral hypoglycemic agent against standard care. To maximize external validity, the study enrolls unselected patients at routine primary care visits without strict adherence protocols, assessing outcomes through electronic health records.
A quality improvement team plans to introduce a novel hand hygiene protocol across 15 hospital units. Because the intervention cannot be deployed everywhere simultaneously due to logistical constraints, units are randomly assigned to sequentially transition from standard care to the new protocol over a 12-month period.

Matches

Show answer & explanation

Answer

The correct matches are: Scenario 1 with Case-crossover study; Scenario 2 with Ecological study; Scenario 3 with Pragmatic clinical trial; Scenario 4 with Stepped-wedge cluster randomized trial.
Each clinical research scenario possesses defining characteristics that dictate the optimal study design. Scenario 1 utilizes the patient as their own control to study a transient trigger, which is the hallmark of a case-crossover study. Scenario 2 analyzes population-level aggregate data rather than individual patient data, characterizing an ecological study. Scenario 3 focuses on maximizing external validity by testing an intervention in a routine, real-world clinical setting without strict exclusion criteria, which defines a pragmatic clinical trial. Scenario 4 involves a sequential, unidirectional rollout of an intervention to randomized clusters over time, typical of a stepped-wedge cluster randomized trial when simultaneous implementation is not feasible.

Step-by-Step Solution

1
Analyze the exposure and outcome variables in the first scenario.
The scenario describes a transient exposure (acute anger) and an acute outcome (sudden cardiac death) where the patient serves as their own control.
Identifying the timing of exposure and the within-person control selection is essential to distinguish a case-crossover design from a traditional case-control design.
2
Examine the data source in the second scenario.
The scenario relies on aggregated national data rather than individual-level patient data.
The unit of observation (population vs. individual) is the defining characteristic of an ecological study.
3
Identify the primary goal and setting of the third scenario.
The trial aims for external validity by evaluating the intervention on unselected patients in a real-world primary care setting without strict protocols.
Distinguishing between explanatory trials (ideal, highly controlled conditions) and pragmatic trials (real-world conditions) is necessary to categorize the design.
4
Determine the randomization and implementation method in the fourth scenario.
Randomization occurs at the unit level (clusters) and the intervention rolls out sequentially over time until all units receive it.
Sequential cluster rollout over time is the defining feature of a stepped-wedge cluster randomized trial.

Key Concept

Advanced epidemiological study designs for specific methodological constraints
Question 2891Question →

Match each of the following ambulatory patients with the single most appropriate screening recommendation according to current United States Preventive Services Task Force (USPSTF) guidelines.

Click a left item, then click its matching right item

Items

A 70-year-old biological male presenting to the ambulatory clinic. He smoked 3 cigarettes daily from age 18 to 24 but has not smoked since. His last colonoscopy was 5 years ago, and he had a normal lipid panel last month.
A 42-year-old biological female presenting for a wellness visit. She has never smoked, has a BMI of 31 kg/m^2, and had a normal Pap smear 2 years ago. She has no known medical conditions.
A 58-year-old biological female in the clinic for follow-up. She smoked 1.5 packs of cigarettes daily for 20 years and quit 12 years ago. She had a normal mammogram and normal colonoscopy 2 years ago.
A 23-year-old biological female presenting for contraceptive counseling. She is a lifelong nonsmoker, sexually active with a new male partner, and had a normal physical exam today. She has never been tested for sexually transmitted infections.

Matches

Show answer & explanation

Answer

The correct pairings match the 70-year-old male with an abdominal ultrasound, the 42-year-old female with diabetes screening, the 58-year-old female with low-dose CT, and the 23-year-old female with chlamydia/gonorrhea testing.
Each patient profile directly aligns with specific USPSTF grade A or B recommendations based on their age, sex, BMI, and exposure history. The 70-year-old male needs an abdominal ultrasound for AAA screening due to his age and lifetime smoking history of >100 cigarettes. The 42-year-old female requires diabetes screening due to her age and elevated BMI. The 58-year-old female requires a low-dose CT scan because she meets the 20 pack-year threshold and quit within the last 15 years. The 23-year-old female needs STI screening because she is sexually active and under the age of 25.

Step-by-Step Solution

1
Evaluate the 70-year-old male's risk factors based on age and exposure.
Identify that a male aged 65-75 with a history of smoking >100 cigarettes needs one-time AAA screening.
USPSTF guidelines mandate a one-time abdominal ultrasound for this exact demographic to prevent catastrophic aneurysm rupture.
2
Evaluate the 42-year-old female's risk factors based on age and biometrics.
Identify that her age (35-70) and BMI (>25 kg/m^2) meet criteria for diabetes screening.
USPSTF recommends HbA1c or fasting glucose for overweight adults in this age range to catch prediabetes early.
3
Evaluate the 58-year-old female's smoking history.
Calculate her smoking history as 30 pack-years (1.5 packs x 20 years) and note she quit 12 years ago.
She meets criteria for annual low-dose CT lung cancer screening because she is 50-80 years old, has a >20 pack-year history, and quit <15 years ago.
4
Evaluate the 23-year-old female's demographics.
Note she is under 25 and sexually active.
USPSTF recommends annual chlamydia and gonorrhea screening for all sexually active women 24 years or younger.

Key Concept

Current USPSTF guidelines for age- and risk-appropriate preventive screening.
Estimated Time:2m 0s
Question 2892Question →

A 71-year-old man with metastatic pancreatic adenocarcinoma and an irreversible malignant bowel obstruction is receiving acute inpatient care. Following extensive multidisciplinary discussions, the patient and his surrogate decision-maker have decided to prioritize quality of life and wish to pursue comfort measures at home. Arrange the following steps in the correct chronological sequence to appropriately execute this patient's disposition and transition to home hospice care.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence for transitioning a patient to home hospice is: 1) Establish terminal prognosis and goals, 2) Obtain formal hospice benefit election, 3) Modify inpatient orders to focus on comfort, 4) Coordinate delivery of home equipment and medications, and 5) Transfer primary care oversight to the hospice agency.
Transitioning a patient to home hospice requires a step-wise approach to ensure legal compliance, patient comfort, and a safe home environment. Clinical prognostication and goal-setting must occur first to medically justify hospice eligibility. This is immediately followed by obtaining legal consent (hospice election). Once consent is obtained, the acute care team modifies current inpatient orders to stop distressing, non-palliative care while the patient remains in the hospital. Concurrently, the destination (home) must be prepared with necessary equipment and comfort medications before the patient can physically leave. Finally, the physical transfer occurs alongside the formal handoff of clinical responsibility.

Step-by-Step Solution

1
Determine eligibility and goals
Prognosis documented and goals aligned
Hospice care requires a physician-certified life expectancy of 6 months or less if the disease runs its normal course.
2
Secure legal and administrative consent
Hospice benefit formally elected
The patient or surrogate must officially waive traditional insurance coverage for curative treatments related to the terminal illness.
3
Implement palliation in the acute setting
Discontinuation of invasive or routine diagnostics
Immediate modification of inpatient orders prevents unnecessary suffering (e.g., morning blood draws) while the physical discharge is being arranged.
4
Prepare the receiving environment
Equipment and medications secured at the residence
A safe transition requires that symptom management tools (e.g., oxygen, opioids) are physically present at home before the patient arrives.
5
Execute transfer and clinical handoff
Patient transferred to home hospice oversight
Primary case management officially shifts from the acute care hospitalist to the hospice medical director and interdisciplinary team.

Key Concept

Chronological workflow for safe transitions from acute inpatient care to home hospice.
Question 2893Question →

Match each clinical presentation of nausea and vomiting in the palliative care setting with the most appropriate targeted initial pharmacologic intervention based on its underlying pathophysiologic mechanism.

Click a left item, then click its matching right item

Items

A patient with advanced malignancy presenting with nausea, early satiety, and upper abdominal bloating, without evidence of mechanical bowel obstruction.
A patient with widely metastatic lung cancer who develops early morning projectile vomiting and a progressive global headache.
A patient receiving palliative chemotherapy who experiences acute, severe emesis beginning 6 hours after an infusion of highly emetogenic agents.
A patient with terminal illness whose nausea and emesis are strictly exacerbated by head turning and transitioning from a supine to a seated position.

Matches

Show answer & explanation

Answer

The correct mapping aligns each presentation of nausea with its pathophysiologic mechanism: gastroparesis requires metoclopramide, increased intracranial pressure requires dexamethasone, acute chemotherapy-induced nausea requires ondansetron, and vestibular nausea requires scopolamine.
Each match represents the standard of care for targeted antiemetic therapy in palliative medicine. Early satiety and bloating suggest gastroparesis, best treated with the prokinetic metoclopramide. Morning vomiting with headache suggests increased intracranial pressure, treated with dexamethasone to reduce edema. Acute nausea after chemotherapy is mediated by serotonin, treated with ondansetron. Movement-triggered nausea is vestibular, treated with scopolamine.

Step-by-Step Solution

1
Identify the primary underlying mechanism of nausea for each patient presentation based on key clinical clues.
Mechanisms identified: autonomic gastroparesis (early satiety), increased intracranial pressure (morning vomiting/headache), serotonin-mediated toxicity (post-chemotherapy), and vestibular stimulation (positional triggers).
Nausea in palliative care is multifactorial; determining the dominant pathway is essential for selecting effective, targeted therapy rather than relying on broad-spectrum agents.
2
Match the identified mechanism to the corresponding receptor-specific drug class and pharmacological agent.
Gastroparesis pairs with prokinetics (metoclopramide); increased intracranial pressure pairs with corticosteroids (dexamethasone); acute chemotherapy-induced nausea pairs with 5-HT3 antagonists (ondansetron); and vestibular nausea pairs with anticholinergics (scopolamine).
Targeting the specific neuroreceptor pathway (D2, 5-HT3, ACh, or direct pressure reduction) maximizes symptomatic relief while minimizing unnecessary side effects.

Key Concept

In palliative care, the treatment of nausea and vomiting must be mechanism-based, utilizing targeted pharmacologic agents that antagonize the specific pathways (e.g., dopamine, serotonin, histamine, acetylcholine) mediating the patient's symptoms.
Question 2894Question →

Critical care investigators are designing a clinical trial to evaluate two experimental therapeutic strategies for patients admitted with severe sepsis-induced acute respiratory distress syndrome (ARDS). The two interventions being evaluated are a targeted intravenous fluid restriction protocol (compared to standard fluid management) and an early continuous neuromuscular blockade protocol (compared to on-demand paralytics). The primary outcome is 28-day ventilator-free survival. The researchers hypothesize that while each intervention alone may improve outcomes, the combination of both strategies will demonstrate a significant synergistic benefit, yielding a survival rate greater than the sum of their individual effects. Which of the following randomized controlled trial designs is most appropriate for efficiently assessing both the individual effects of these interventions and their potential interaction?

Show answer & explanation

Answer: Factorial design

Answer

Factorial design
The correct study design is a factorial design. In a 2×22 \times 2 factorial clinical trial, participants are randomly assigned to one of four groups: standard care only, intervention A only, intervention B only, or both intervention A and B. This specific design allows investigators to efficiently study the independent effects of each treatment (main effects) while simultaneously determining if there is an interaction (synergy or antagonism) between them. Because the researchers explicitly hypothesize a synergistic benefit, the factorial design is structurally required.

Step-by-Step Solution

1
Identify the primary research objective in the clinical vignette.
The investigators want to test two different interventions (fluid restriction and neuromuscular blockade) and specifically determine if there is a synergistic effect (interaction) when both are used together.
Study design selection strictly depends on the research question, the nature of the interventions, and the hypothesized outcomes.
2
Evaluate the patient population and disease state.
The patients have severe sepsis-induced ARDS, an acute and highly lethal condition.
This rules out any study design that requires a stable chronic baseline or a washout period, such as a crossover trial.
3
Match the requirement for testing interaction/synergy with the correct trial topology.
A factorial design assigns patients into a grid (e.g., 2×22 \times 2), allowing them to receive Neither, Intervention 1 only, Intervention 2 only, or Both.
This is the only standard study design that mathematically and efficiently calculates both the independent main effects and the interaction (effect modification) between two separate variables.

Key Concept

In clinical research, a factorial design is the optimal randomized structure to evaluate two or more distinct interventions simultaneously, specifically allowing investigators to measure interactions (synergistic or antagonistic effects) between the therapies.
Question 2895Question →

A 35-year-old man comes to the clinic for a routine health maintenance visit. He has a history of bipolar I disorder, which has been well-controlled on lithium monotherapy for the past 5 years. He reports no recent manic or depressive episodes and states that his mood has been highly stable. He denies polyuria, polydipsia, fatigue, or unintentional weight changes. He takes no other medications and has no other known medical conditions. Vital signs are within normal limits, and the physical examination is unremarkable. A recent serum lithium level was 0.8 mEq/L0.8 \text{ mEq/L} (therapeutic range: 0.6−1.2 mEq/L0.6-1.2 \text{ mEq/L}). Which of the following laboratory studies are indicated for routine ongoing monitoring of this patient's long-term pharmacotherapy? (Select three)

Select all that apply

Show answer & explanation

Answer: Serum creatinine; Thyroid-stimulating hormone; Serum calcium

Answer

The correct parameters for ongoing lithium monitoring are serum creatinine, thyroid-stimulating hormone, and serum calcium.
Lithium has a narrow therapeutic index and several well-established, long-term adverse effects affecting specific organ systems. It is primarily excreted unchanged by the kidneys and can cause chronic tubulointerstitial nephropathy or nephrogenic diabetes insipidus, necessitating periodic monitoring of renal function via serum creatinine. Lithium also frequently causes thyroid dysfunction (most commonly hypothyroidism) by interfering with the synthesis and release of thyroid hormones, requiring regular assessment of thyroid-stimulating hormone (TSH). Additionally, lithium can alter calcium metabolism and lead to hypercalcemia via medication-induced hyperparathyroidism; thus, serum calcium levels should also be periodically evaluated. In clinically stable patients on maintenance therapy, these parameters are typically checked every 6 to 12 months.

Step-by-Step Solution

1
Identify the patient's current medication and its known long-term adverse effects.
The patient is on long-term lithium therapy. Chronic lithium use is known to be toxic to the kidneys, the thyroid gland, and the parathyroid glands.
Recognizing the organ-specific toxicity profile of a drug is essential for selecting appropriate, guideline-concordant surveillance tests.
2
Select the specific laboratory tests that screen for these drug-induced organ toxicities.
Serum creatinine evaluates for lithium-induced nephropathy, thyroid-stimulating hormone screens for hypothyroidism, and serum calcium screens for hyperparathyroidism.
Standard psychiatric guidelines mandate periodic monitoring of these exact parameters to detect asymptomatic complications early.
3
Differentiate lithium's monitoring requirements from those of other psychotropic medications.
Tests like transaminases, complete blood counts, and hemoglobin A1c are excluded because they track toxicities of other drug classes.
This prevents ordering unnecessary diagnostic tests and avoids confusing lithium's profile with that of valproate, carbamazepine, or atypical antipsychotics.

Key Concept

Patients on maintenance lithium therapy require periodic monitoring of renal function (serum creatinine/BUN), thyroid function (thyroid-stimulating hormone), and parathyroid function (serum calcium) due to the drug's long-term organ toxicities.
Question 2896Question →

A multidisciplinary task force at a tertiary care hospital is developing a study protocol to investigate prophylactic interventions for postoperative delirium in patients over 65 years of age undergoing major orthopedic surgery. The research team plans to evaluate two separate interventions: a single dose of intravenous haloperidol administered immediately post-surgery, and a standardized non-pharmacologic care bundle focused on sleep hygiene and early mobilization.

The investigators specifically aim to assess the independent effect of the haloperidol, the independent effect of the care bundle, and whether the simultaneous use of both interventions provides a synergistic benefit that exceeds the additive effects of each alone. Furthermore, they wish to answer all three clinical questions using the most statistically efficient patient sample size possible.

Which of the following research designs is most appropriate for this investigation?

Show answer & explanation

Answer: Factorial design

Answer

Factorial design
The correct answer is a factorial design. In this specific scenario, a 2x2 factorial design would randomize individual patients into one of four distinct groups: haloperidol only, care bundle only, both interventions simultaneously, and standard care (neither intervention). This design is highly statistically efficient because it utilizes the entire study population to assess the main effect of each intervention. For instance, the main effect of haloperidol is evaluated by comparing all patients who received it (the haloperidol-only group plus the combination group) against all patients who did not receive it. Most importantly, the factorial design is specifically structured to allow for the statistical evaluation of interaction (such as synergy or antagonism) between the two interventions, fulfilling all of the investigators' objectives.

Step-by-Step Solution

1
Analyze the investigator's objectives.
The goal is to test two independent interventions, assess their individual main effects, and determine if there is a synergistic effect (interaction) when used together.
Identifying the specific hypotheses to be tested dictates the required structural elements of the study design.
2
Evaluate the constraints.
The design must achieve these goals using the most statistically efficient sample size possible.
Efficiency eliminates designs that require multiple separate trials or those that inherently inflate required sample sizes (like cluster randomization).
3
Select the optimal design matching the parameters.
A 2x2 factorial design randomizes participants to four groups (Drug only, Protocol only, Both, Neither).
This design utilizes the entire cohort to calculate main effects and is the standard methodology for evaluating interaction (synergy).

Key Concept

Factorial clinical trial design
Estimated Time:1m 30s
Question 2897Question →

An 85-year-old man is evaluated for discharge planning. He was admitted 8 days ago for urosepsis complicated by a non-ST-segment elevation myocardial infarction (NSTEMI). He spent 4 days in the intensive care unit requiring vasopressor support and was subsequently transferred to the medical ward. He is now hemodynamically stable, afebrile, and his white blood cell count has normalized to 7,500/mm³. He is currently receiving a 14-day course of intravenous ceftriaxone via a peripherally inserted central catheter (PICC) and has 6 days of therapy remaining.

Prior to admission, the patient lived at home with his 82-year-old wife and ambulated independently with a cane. His wife has severe osteoarthritis and uses a wheeled walker for mobility.

Currently, the patient is alert and oriented to person, place, and time. Physical examination reveals generalized muscle weakness. Physical and occupational therapy evaluations indicate that he requires maximal assistance for bed-to-chair transfers and cannot ambulate safely. He fatigues rapidly during therapy sessions, tolerating a maximum of 30 minutes of active physical rehabilitation per day due to cardiopulmonary deconditioning.

Which of the following is the most appropriate disposition for this patient?

Show answer & explanation

Answer: Discharge to a skilled nursing facility

Answer

Discharge to a skilled nursing facility
The correct disposition is discharge to a skilled nursing facility (SNF). This patient requires a structured environment for three specific reasons: completion of intravenous antibiotics, assistance with severe functional deficits (maximal assist for transfers), and physical therapy to recover from post-ICU deconditioning. Because his wife has severe osteoarthritis and uses a walker, she cannot safely assist him with transfers at home, making a home discharge unsafe even with intermittent home health visits. Furthermore, his cardiopulmonary deconditioning limits his therapy tolerance to only 30 minutes per day. This explicitly disqualifies him from an inpatient rehabilitation facility (IRF), which strictly requires patients to be capable of participating in at least 3 hours of intensive therapy daily. An SNF bridges this gap by providing daily skilled nursing care (IV medications), subacute physical therapy at a tolerable pace, and the 24-hour custodial support necessary for his safety.

Step-by-Step Solution

1
Assess the patient's ongoing medical and functional needs.
The patient requires 6 additional days of intravenous antibiotics, physical therapy for severe post-ICU deconditioning, and maximal assistance for transfers.
Identifying ongoing requirements establishes the baseline level of care required after hospital discharge.
2
Evaluate the patient's functional capacity and tolerance for rehabilitation.
The patient can only tolerate 30 minutes of therapy per day due to cardiopulmonary fatigue.
Rehabilitation tolerance is the primary differentiator between acute inpatient rehabilitation (requires 3 hours/day) and subacute rehabilitation (accommodates lower endurance).
3
Assess the social support system and home environment safety.
The patient's wife uses a walker and is physically unable to assist with maximal-assist transfers.
A safe discharge home requires either patient independence or a capable caregiver; without either, a facility-based disposition is mandatory to prevent falls and caregiver injury.
4
Synthesize findings to select the appropriate facility.
A skilled nursing facility (SNF) is selected.
An SNF safely provides the necessary IV antibiotic administration, subacute rehabilitation tailored to his low endurance, and 24-hour assistance with activities of daily living.

Key Concept

Disposition to post-acute care settings requires matching the patient's medical needs, rehabilitation tolerance (e.g., IRF vs. SNF criteria), and available home support structure to ensure safe transitions of care.
Question 2898Question →

A physician evaluates a 62-year-old female patient who presents for a scheduled health maintenance visit. Her past medical history is notable for hypertension, osteoarthritis, and a total abdominal hysterectomy with bilateral salpingo-oophorectomy performed for symptomatic uterine fibroids at age 45. She has consumed half a pack of cigarettes per day continuously since she was 22 years old. She currently takes amlodipine and acetaminophen. She reports feeling well without any new symptoms. Physical examination shows a blood pressure of 126/78 mm Hg and a body mass index of 24 kg/m². A recently calculated 10-year major osteoporotic fracture risk using the FRAX assessment tool is 4.2%.

Review of her preventive care timeline demonstrates:
- A colonoscopy at age 54 with no abnormal findings.
- A screening mammogram completed 6 months ago that was interpreted as normal.
- A negative Hepatitis C virus antibody assay at age 58.
- Documentation of the 20-valent pneumococcal conjugate vaccine (PCV20) administered at age 60, alongside an up-to-date annual influenza vaccination.

Which of the following interventions is the most appropriate next step in this patient's preventive care?

Show answer & explanation

Answer: Annual low-dose computed tomography of the chest

Answer

Annual low-dose computed tomography of the chest
The correct answer is annual low-dose computed tomography of the chest. The United States Preventive Services Task Force (USPSTF) recommends annual lung cancer screening with low-dose computed tomography (LDCT) for adults aged 50 to 80 years who have at least a 20 pack-year smoking history and currently smoke or have quit within the past 15 years. This patient has smoked 0.5 packs per day for 40 years (from age 22 to 62), which equates to exactly a 20 pack-year history. Because she meets the age criteria, meets the updated pack-year threshold, and is a current smoker, LDCT is strongly indicated to reduce lung cancer-specific mortality.

Step-by-Step Solution

1
Calculate the patient's smoking pack-year history.
The patient has smoked 0.5 packs per day for 40 years (from age 22 to 62). 0.5 x 40 = 20 pack-years.
Accurate pack-year calculation is essential to determine eligibility for lung cancer screening.
2
Evaluate the patient against USPSTF lung cancer screening criteria.
She is between 50 and 80 years old, has exactly a 20 pack-year history, and currently smokes. Therefore, she meets all indications for annual screening.
To identify if a high-value, mortality-reducing preventive intervention is currently due.
3
Assess the necessity of other preventive screenings based on her specific history.
Colonoscopy is deferred until age 64 (10 years after a normal result). Cervical screening is contraindicated due to prior total hysterectomy for benign disease. DEXA is deferred because she is under 65 and her FRAX score (4.2%) is below the 8.4% threshold. AAA screening is not routinely indicated in women.
To systematically eliminate distractors that represent mistimed or inappropriate care.

Key Concept

The USPSTF recommends annual lung cancer screening with low-dose computed tomography (LDCT) for adults aged 50 to 80 years with a 20 pack-year smoking history who currently smoke or have quit within the past 15 years.

Alternative Method

Calculate pack-years by multiplying the total number of cigarettes smoked per day by the number of years smoked, then dividing by 20 (the standard number of cigarettes in a pack). (10 cigarettes/day * 40 years) / 20 = 20 pack-years.
Estimated Time:1m 30s
Question 2899Question →

Match each clinical research scenario with the most appropriate epidemiological study design it describes.

Click a left item, then click its matching right item

Items

Investigators identify a group of patients with cryptogenic organizing pneumonia and a group of healthy individuals, then interview both groups regarding their historical environmental exposures.
Reviewing archived hospital records from 2010 to 2015, investigators identify pregnant individuals based on their influenza vaccination status and examine delivery records to compare preterm birth rates.
Researchers enroll 5,000 healthy volunteers from a community clinic, collect baseline dietary data, and monitor them annually for ten years to evaluate the incidence of colorectal cancer.
Patients with refractory major depressive disorder are randomized to receive an SSRI alone, cognitive behavioral therapy (CBT) alone, both the SSRI and CBT, or dual placebos to evaluate independent and synergistic therapeutic effects.

Matches

Show answer & explanation

Answer

The scenarios match as follows: The pneumonia exposure recall is a Case-Control Study; the archived vaccination records analysis is a Retrospective Cohort Study; the ten-year dietary follow-up is a Prospective Cohort Study; and the randomized depression treatment combinations form a Factorial Design Trial.
The correct matches rely on identifying the defining methodology for each design: case-control studies begin with the disease; retrospective cohorts begin with historical exposure; prospective cohorts begin with current exposure; and factorial trials use combinations of randomized treatments.

Step-by-Step Solution

1
Analyze the participant selection method for each scenario.
The first scenario selects based on disease presence. The second and third scenarios select based on exposure status. The fourth utilizes randomization to multiple intervention groups.
The primary distinction between observational study designs relies on whether participants are grouped by their exposure or their outcome status.
2
Determine the temporal direction of data collection for the observational studies.
The first scenario looks backward for past exposure. The second scenario looks forward from a past date using existing records. The third scenario looks forward from the present in real-time.
Temporal direction differentiates prospective cohorts from retrospective cohorts and case-control studies.

Key Concept

Epidemiological study designs are classified by their participant selection criteria (exposure vs. outcome), temporal direction (prospective vs. retrospective), and presence of randomized interventions.
Question 2900Question →

A 62-year-old woman is admitted to the hospital with a 2-day history of acute right leg swelling and right-sided pleuritic chest pain. She has a history of type 2 diabetes mellitus, hypertension, and chronic kidney disease stage 4. Her home medications include amlodipine, insulin glargine, and atorvastatin. On presentation, her blood pressure is 138/85 mmHg, pulse is 105/min, and oxygen saturation is 94% on room air. Laboratory studies show a serum creatinine of 3.2 mg/dL3.2 \text{ mg/dL} (estimated glomerular filtration rate: 18 mL/min/1.73 m218 \text{ mL/min/1.73 m}^2). A computed tomography (CT) pulmonary angiogram confirms a right lower lobe segmental pulmonary embolism. A comprehensive lower extremity venous ultrasound demonstrates a proximal deep vein thrombosis in the right popliteal vein. Continuous intravenous unfractionated heparin is initiated.

Which of the following are necessary components of this patient's ongoing treatment and monitoring plan? (Select two)

Select all that apply

Show answer & explanation

Answer: Serial measurement of activated partial thromboplastin time (aPTT) every 6 hours until the therapeutic target is achieved; Monitoring of the platelet count every 2 to 3 days to evaluate for drug-induced complications

Answer

The correct monitoring parameters are the serial measurement of activated partial thromboplastin time (aPTT) to ensure therapeutic anticoagulation and regular monitoring of the platelet count to assess for heparin-induced thrombocytopenia.
The use of intravenous unfractionated heparin requires precise monitoring due to its unpredictable pharmacokinetic profile. Efficacy is monitored by checking the activated partial thromboplastin time (aPTT) every 6 hours after initiation or dose adjustments until two consecutive values are within the target therapeutic range. Furthermore, because unfractionated heparin carries a high risk of heparin-induced thrombocytopenia (HIT), patients must have their platelet counts monitored regularly (e.g., every 2 to 3 days from day 4 to 14 of therapy) to identify a precipitous drop that would necessitate immediate cessation of heparin and transition to a non-heparin anticoagulant.

Step-by-Step Solution

1
Evaluate the patient's clinical presentation, comorbidities, and current therapy.
The patient has an acute pulmonary embolism and deep vein thrombosis in the setting of severe chronic kidney disease (eGFR 18 mL/min/1.73 m218 \text{ mL/min/1.73 m}^2) and is appropriately started on intravenous unfractionated heparin (UFH).
Severe renal impairment restricts the use of low-molecular-weight heparins (like enoxaparin) and most direct oral anticoagulants due to the risk of bioaccumulation and fatal bleeding. UFH is primarily cleared by the reticuloendothelial system and is the safest initial option.
2
Identify the appropriate efficacy monitoring for intravenous unfractionated heparin.
The intrinsic and common coagulation pathways must be monitored using the activated partial thromboplastin time (aPTT).
UFH binds to antithrombin, enhancing its inactivation of thrombin (Factor IIa) and Factor Xa. The aPTT is measured every 6 hours until therapeutic (typically 1.5 to 2.5 times the control value), then daily.
3
Identify the required safety monitoring for unfractionated heparin therapy.
The patient requires regular monitoring of her platelet count.
UFH carries a significant risk of inducing heparin-induced thrombocytopenia (HIT), an immune-mediated prothrombotic state caused by antibodies against heparin-platelet factor 4 complexes.

Key Concept

Patients with acute venous thromboembolism and severe renal impairment should be treated with intravenous unfractionated heparin, which requires frequent aPTT monitoring to ensure therapeutic dosing and serial platelet count monitoring to detect heparin-induced thrombocytopenia.
PreviousPage 145 / 237Next
All practice questions — USMLE Step 3 | Examkin